Exome Asset Management LLC Acadia Pharmaceuticals Inc Call Options Transaction History
Exome Asset Management LLC
- $135 Billion
- Q2 2025
Call Options
1 transactions
Others Institutions Holding ACAD
# of Institutions
353Shares Held
164MCall Options Held
811KPut Options Held
334K-
Baker Bros. Advisors LP New York, NY42.9MShares$960 Million9.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.3MShares$341 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$270 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY9MShares$201 Million2.98% of portfolio
-
State Street Corp Boston, MA6.18MShares$138 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.62B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...